Cisatracurium 63323-0417
Generic: Cisatracurium Besylate
Product NDC
63323-0417- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 26, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA203183
Need to source Cisatracurium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cisatracurium Besylate | 2 mg/mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Packaging Options(1)
10 VIAL in 1 CARTON (63323-417-10) / 10 mL in 1 VIAL (63323-417-01)